Sofinnova Venture Partners Vii L P Sample Contracts

EXHIBIT E

Sales Plan • September 7th, 2016 • Sofinnova Venture Partners Vii L P • Biological products, (no disgnostic substances)

• Contract Type
  Sales Plan
• Filed
  September 7th, 2016
• Company
  Sofinnova Venture Partners Vii L P
• Industry
  Biological products, (no disgnostic substances)

Sales Plan, adopted August 26, 2016 (the “Sales Plan”), between Sofinnova Venture Partners VII, L.P. (“Seller”) and J.P. Morgan Securities LLC (“JPMS”). The purpose of this Sales Plan is to achieve the investment objectives of broader diversification of investments, while reducing the risk of over concentration in a particular investment.

WARRANT PURCHASE AGREEMENT

Warrant Purchase Agreement • April 9th, 2012 • Sofinnova Venture Partners Vii L P • Pharmaceutical preparations • California

• Contract Type
  Warrant Purchase Agreement
• Filed
  April 9th, 2012
• Company
  Sofinnova Venture Partners Vii L P
• Industry
  Pharmaceutical preparations
• Jurisdiction
  California

This Warrant Purchase Agreement (the “Agreement”), dated as of April 3, 2012, is by and between Sofinnova Venture Partners VII, L.P. (the “Seller”) and OTA LLC (the “Buyer”).

THIS MANAGEMENT RIGHTS DEED OF AGREEMENT (this “Deed”) is made as of October 16, 2009 by and among:

Management Rights Deed of Agreement • October 27th, 2009 • Sofinnova Venture Partners Vii L P • Pharmaceutical preparations • England and Wales

• Contract Type
  Management Rights Deed of Agreement
• Filed
  October 27th, 2009
• Company
  Sofinnova Venture Partners Vii L P
• Industry
  Pharmaceutical preparations
• Jurisdiction
  England and Wales

WARRANT PURCHASE AGREEMENT

Warrant Purchase Agreement • January 17th, 2013 • Sofinnova Venture Partners Vii L P • Pharmaceutical preparations • California

• Contract Type
  Warrant Purchase Agreement
• Filed
  January 17th, 2013
• Company
  Sofinnova Venture Partners Vii L P
• Industry
  Pharmaceutical preparations
• Jurisdiction
  California

This Warrant Purchase Agreement (the “Agreement”), dated as of April 3, 2012, is by and between Sofinnova Venture Partners VII, L.P. (the “Seller”) and OTA LLC (the “Buyer”).

Sales Plan

Sales Plan • September 6th, 2017 • Sofinnova Venture Partners Vii L P • Biological products, (no disgnostic substances)

• Contract Type
  Sales Plan
• Filed
  September 6th, 2017
• Company
  Sofinnova Venture Partners Vii L P
• Industry
  Biological products, (no disgnostic substances)

Sales Plan, adopted August 23, 2017 (the “Sales Plan”), between Sofinnova Venture Partners VII, L.P. (“Seller”) and J.P. Morgan Securities LLC (“JPMS”). The purpose of this Sales Plan is to achieve the investment objectives of broader diversification of investments, while reducing the risk of over concentration in a particular investment.